Compare LENZ & MVBF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LENZ | MVBF |
|---|---|---|
| Founded | 2019 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 310.4M | 338.1M |
| IPO Year | 2021 | 2004 |
| Metric | LENZ | MVBF |
|---|---|---|
| Price | $9.97 | $26.55 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 4 |
| Target Price | ★ $45.60 | $29.50 |
| AVG Volume (30 Days) | ★ 1.1M | 26.8K |
| Earning Date | 05-06-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 2.54% |
| EPS Growth | N/A | ★ 34.64 |
| EPS | N/A | ★ 2.06 |
| Revenue | ★ $19,088,000.00 | $3,400,000.00 |
| Revenue This Year | $51.35 | $1.70 |
| Revenue Next Year | $198.33 | $13.59 |
| P/E Ratio | ★ N/A | $13.00 |
| Revenue Growth | N/A | ★ 51.92 |
| 52 Week Low | $8.25 | $16.03 |
| 52 Week High | $50.19 | $29.59 |
| Indicator | LENZ | MVBF |
|---|---|---|
| Relative Strength Index (RSI) | 47.63 | 55.88 |
| Support Level | $8.99 | $25.22 |
| Resistance Level | $10.29 | $27.33 |
| Average True Range (ATR) | 0.68 | 0.56 |
| MACD | 0.25 | 0.16 |
| Stochastic Oscillator | 87.82 | 74.91 |
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products. Its products VIZZ (aceclidine ophthalmic solution) 1.44% is a once-daily eye drop developed to restore clear near vision for up to 10 hours. VIZZ is powered by aceclidine, highlighted by its differentiated mechanism of action as a predominantly pupil-selective miotic that interacts with the iris, with minimal ciliary muscle stimulation.
MVB Financial Corp is a financial holding company. The company provides a wide range of business activities through the Bank, commercial and retail banking services, as well as Fintech banking. It has three reportable segments: CoRe Banking, Mortgage Banking, and Financial Holding Company. The majority of its revenue is generated from the CoRe Banking segment, which includes its Fintech division, represents banking products and services offered to customers by the Bank, loans and deposits accounts. Revenue from banking activities consists of interest earned on loans and investment securities and service charges on deposit accounts.